For laboratory research use only. Not for human or veterinary use.
Retatrutide vial, Prime Core Dynamics

Retatrutide

Triple GIP, GLP-1 and glucagon receptor agonist

Incretin receptor agonists Research use only
  • Catalog no. RET-60MG-A01
  • Format Lyophilized powder
Buy on primecoredynamics.com View certificate
Size 10 mg selected
Buy on primecoredynamics.com

Purchase requires a research-use acknowledgement at checkout. Prices as listed on primecoredynamics.com; ordering completes there.

Identity and specifications

Identity

Name
Retatrutide
CAS number
2381089-83-2
Molecular formula
C221H342N46O68
Molecular weight
4731.30
Appearance
White
Purity specification
99.9% (HPLC), per certificate
Storage
Refrigerated at 36 to 46°F (2 to 8°C); frozen at minus 4°F (minus 20°C) or below for long-term storage. Keep away from light, moisture and heat.
About this material

Molecule class and status

Retatrutide is a synthetic peptide developed under the code LY3437943. It is characterized in the literature as an agonist at three receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. It is an investigational compound: as of this writing it is in late-stage clinical trials and is not approved for any use in any country. The material supplied here is a lyophilized powder for in-vitro and analytical laboratory work, identified by lot with a third-party certificate of analysis.

Analytical data

Latest lot

RET-60MG-A01
Lot
>99.9%
HPLC purity
Sep 10, 2026
Test date
Krause Analytical
Laboratory

HPLC-UV/MS purity, mass spectral identity. Values as published on the lot certificate.

View certificate
Handling and storage

Chemical properties

  • Physical form: lyophilized powder in a sealed vial.
  • The sealed vial is stable at room temperature during transit and can be held in a cool, dry, dark place for short periods.
  • Beyond short-term holding, store refrigerated at 36 to 46°F (2 to 8°C), or frozen at minus 4°F (minus 20°C) or below for long-term storage.
  • Keep away from light, moisture and heat.
  • Lyophilized material is stable for the period stated on the certificate for the lot.
Research literature

Citations

Citations are provided for reference. Prime Core Dynamics makes no claim based on them.

  1. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metabolism, 2022. doi:10.1016/j.cmet.2022.07.013
Regulatory status

Status

Investigational compound. Retatrutide is in clinical trials and is not approved by the FDA or any other regulator for any use. This material is not a drug, supplement, food or cosmetic and has not been evaluated by the FDA. Sold for laboratory research only.

Statement reviewed against the product's regulatory standing as of Sept 2026.

For laboratory research use only. Not for human or veterinary use. Not a drug, supplement, food or cosmetic. Not evaluated by the FDA.

Documents

Documents